Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitenanobiotix.com
Twitter@Nanobiotix
CategoryBioTech
Phone+ 33 (0) 1 40 26 04 70
Employees
Founded2003

Offices

Paris, FRA
60 rue de Wattignies
Bat B 3rd floor
Paris, 75012, FRA

People

Funding

TOTAL $14.6M
FUNDING TOTAL $14.6M
Series C, 5/2010
CIC Vizille Capital Innovation
OTC Asset Management
Amorçage Rhône Alpes
Seventure Partners
CapDecisif
$11M
Grant, 7/2013
Bpifrance
€2.8M

Tags

Nanobiotix

Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer. The company was incorporated in 2003 and is based in Paris, France.

Recent Milestones

Videos

Screenshots

Sources

  1. Nanobiotix, S.A.: Series C $11M (onbiovc.com) [edit]
  2. Nanobiotix announces €2.8 million grant from bpifrance to accelerate development of NBTXR3 in a third new indication (nanobiotix.com) [edit]
Edit This Page
Last Edited 11/24/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy